Special Issue "Plant Medicines for Clinical Trial"
A special issue of Medicines (ISSN 2305-6320).
Deadline for manuscript submissions: closed (30 April 2017).
A printed edition of this Special Issue is available here.
The body heals itself. The purpose of medicines is to help the body heal. When the body is in balance, it can heal itself of many conditions, in other words, prevent many diseases . Patients should be taught what balance is and how to maintain balance.
Drugs are not magic bullets that cure diseases. Even antibiotics and anticancer drugs are of no use when the immune and defense systems are not functioning well. In many clinical trials, the placebo works as well as the drug, because of the body's ability to heal itself.
Plant medicines have been used since the beginning of the humanity. People who survived because of plant-based medicines, passed on their genes. Our genes have evolved under this selective pressure. We should continue to use plant-based medicines.
Clinical trials are useful to demonstrate what a plant medicine can be used to treat, and to demonstrate safety. Useful information can be derived from placebo controlled clinical trials, from clinical trials that compare a new medicine to an old medicine, and from other clinical trials. Many different clinical trial designs are appropriate.
Clinical trials are frequently abused. Drugs are shown to help with one disease symptom and are approved for use, even though they are very toxic. Many of the oral medicines used to treat pain are dangerous drugs that kill many patients. Some of the drugs approved for type 2 diabetes cause heart disease. Some of the drugs approved for heart disease cause type 2 diabetes.
Drugs are frequently used as if they were the only possible treatment for a disease. Prevention may be the best treatment for many chronic diseases that plague the modern world.
Dr. James David Adams
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
 Adams, J. The balanced diet for you and the planet. Abedus Press, La Crescenta, 2014.